Home > Cashflow Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cashflow Statement

GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Cashflow Statement History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Profit Before Tax₹1,985 Cr₹1,399 Cr₹569 Cr₹868 Cr₹1,441 Cr
Adjustment ₹2,690 Cr₹947 Cr₹1,010 Cr₹1,472 Cr₹787 Cr
Changes In working Capital ₹-447 Cr₹-2,494 Cr₹-797 Cr₹-1,074 Cr₹-561 Cr
Cash Flow after changes in Working Capital ₹4,228 Cr₹-147 Cr₹782 Cr₹1,266 Cr₹1,667 Cr
Cash Flow from Operating Activities ₹3,445 Cr₹-828 Cr₹-265 Cr₹625 Cr₹1,109 Cr
Cash Flow from Investing Activities ₹-1,283 Cr₹2.09 Cr₹4,561 Cr₹-528 Cr₹-333 Cr
Cash Flow from Financing Activities ₹-2,709 Cr₹787 Cr₹-3,906 Cr₹-77 Cr₹-520 Cr
Net Cash Inflow / Outflow ₹-547 Cr₹-38 Cr₹389 Cr₹19 Cr₹255 Cr
Opening Cash & Cash Equivalents ₹1,676 Cr₹1,658 Cr₹1,443 Cr₹1,411 Cr₹1,138 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger ---₹0.67 Cr-
Cash & Cash Equivalent of Subsidiaries under liquidations --₹-192 Cr--
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹46 Cr₹56 Cr₹18 Cr₹12 Cr₹18 Cr
Closing Cash & Cash Equivalent ₹1,175 Cr₹1,676 Cr₹1,658 Cr₹1,443 Cr₹1,411 Cr

Compare Cashflow Statement of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹70,263.6 Cr 4% 11.5% 28.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹469,310.0 Cr 2% -1.7% 15.9% Stock Analytics
DIVIS LABORATORIES ₹245,426.0 Cr 6.5% 14.8% 48.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,347.0 Cr 1.2% -2.5% 37.2% Stock Analytics
CIPLA ₹114,393.0 Cr -0.3% -3.9% -11.4% Stock Analytics
DR REDDYS LABORATORIES ₹97,240.2 Cr -2.2% 1.5% -8.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

4%

11.5%

28.7%

SENSEX

-0.5%

-1.3%

-5.4%


You may also like the below Video Courses